All are true regarding selective estrogen receptor down–regulator (SERD), Fulvestrant except:: (A) Used for treatment of advanced breast cancer, (B) Is a selective estrogen antagonist, (C) Is slower and short acting and less safer than SERMs, (D) Administered as once a month i.m. dose
Answer is C. None